Stephanie Dulucq

18PUBLICATIONS
100CO-AUTHORS
Predictive and prognostic markersHaematological tumoursHaematologyMolecular evolutionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 15, 2026
Development and External Validation of a Transcriptome-Based Multivariable Prediction Model for Treatment-Free Remission in Chronic Myeloid Leukemia.

|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.

Vincent Jachiet, Olivier Kosmider, Maxime Beydon

|Aug 30, 2024
Characterization and Clinical Significance of Hemolysis After Pulsed Field Ablation for Atrial Fibrillation: Results of a Multicenter Analysis.

Miruna A Popa, Sandrine Venier, Roberto Menè

|Aug 19, 2024
Beta-thalassaemia intermedia due to a complex alpha-globin rearrangement and a heterozygous beta thalassaemia mutation.

Victor Marin, Yoann Huguenin, Lucile Bessi

|Mar 12, 2024
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission.

Francois-Xavier Mahon, Markus Pfirrmann, Stéphanie Dulucq

|Apr 02, 2023
Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment-free remission period after imatinib discontinuation: Results of the French Nilo post-STIM study.

Stéphanie Dulucq, Françoise Rigal-Huguet, Franck E Nicolini

Pageof 3

Frequent Collaborators

6 joint publications

Gabriel Etienne

4 joint publications

Delphine Rea

2 joint publications

Franck E Nicolini

2 joint publications

Joëlle Guilhot